Journal Article


Utilising extracellular vesicles for early cancer diagnostics: benefits, challenges and recommendations for the future

Abstract

To increase cancer patient survival and wellbeing, diagnostic assays need to be able to detect cases earlier, be applied more frequently, and preferably before symptoms develop. The expansion of blood biopsy technologies such as detection of circulating tumour cells and cell-free DNA has shown clinical promise for this. Extracellular vesicles released into the blood from tumour cells may offer a snapshot of the whole of the tumour. They represent a stable and multifaceted complex of a number of different types of molecules including DNA, RNA and protein. These represent biomarker targets that can be collected and analysed from blood samples, offering great potential for early diagnosis. In this review we discuss the benefits and challenges of the use of extracellular vesicles in this context and provide recommendations on where this developing field should focus their efforts to bring future success.

Attached files

Authors

Pink, Ryan C.
Beaman, Ellie-May
Samuel, Priya
Brooks, Susan A.
Carter, David R.F.

Oxford Brookes departments

Department of Biological and Medical Sciences

Dates

Year of publication: 2022
Date of RADAR deposit: 2022-01-11



“Copyright © 2022, Springer Nature. Users may view, print, copy, download and text and data-mine the content, for the purposes of academic research, subject always to the full conditions of use. Any further use is subject to permission from Springer Nature.”


Related resources

This RADAR resource is the Accepted Manuscript of Utilising extracellular vesicles for early cancer diagnostics: benefits, challenges and recommendations for the future

Details

  • Owner: Daniel Croft
  • Collection: Outputs
  • Version: 1 (show all)
  • Status: Live